April 1, 2009 - Endovascular aortic repair (EVAR) used to repair ruptured abdominal aortic aneurysms (RAAAs) had a significant mortality benefit, according to five-year study published in the April issue of the Journal of Vascular Surgery.

The study, conducted by researchers from the University of Massachusetts Memorial Medical Center’s division of vascular and endovascular surgery in Worcester, examined the national frequency, predictors, outcomes, and the effect of institutional volume metrics in cases where endovascular aortic repair (EVAR) was used to repair ruptured abdominal aortic aneurysms (RAAAs) between 2001 and 2006.

Over the years EVAR has gained wide acceptance for the elective treatment of abdominal aortic aneurysms (AAA). This success has led to increased interest in similar treatment of RAAAs, because most patients who suffer a RAAA do not survive long enough to obtain medical care. The mortality rate for patients who do survive and undergo traditional open surgical repair continues to exceed 40 percent.

In this study, an estimated 27,750 hospital discharges for RAAA occurred, of which 11.5 percent were treated with EVAR. Data was secured through the Nationwide Inpatient Sample to evaluate operative outcomes.

"While the incidence of RAAA remained fairly constant, EVAR was used to treat RAAA in an increasing proportion of patients - from 5.9 percent in 2001 to 18.9 percent in 2006," said Andres Schanzer, M.D., assistant professor of surgery in the division. Researchers found that EVAR was independently associated with a lower postoperative mortality risk than was open repair (31.7 percent versus 40.7 percent).

"Elective surgery was the strongest predictor of the use of EVAR for RAAA repairs," added Dr. Schanzer. "The use of EVAR for RAAA also increased in patients more than 80 years of age. Additionally, EVAR patients had a shorter length of stay (11.1 vs. 13.8 days for open repair); more discharges to home (65.1 percent vs. 53.9 percent); and lower hospital charges ($108,672 vs. $114,784)."

Procedure volume was determined for each institution where hospitals were categorized as low, medium or high volume. Researchers noted that even after adjustment for hospital surgical volume characteristics, teaching hospitals continued to show lower mortality risks following RAAA repair than non-teaching hospitals.

Dr. Schanzer said that the study results support regionalization of RAAA repair to high volume centers whenever possible and a wider adoption of endovascular repair nationwide. "Through such a system appropriate patients could be rapidly transferred to institutions with EVAR capabilities, thus potentially decreasing the in-hospital mortality rate for this critically ill patient population," he added.

For more information: www.jvascsurg.org


Related Content

News | Computed Tomography (CT)

September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

Time September 19, 2023
arrow
News | SPECT-CT

September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...

Time September 12, 2022
arrow
News | Contrast Media

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

Time August 02, 2022
arrow
News | Mobile C-Arms

July 29, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ...

Time July 29, 2022
arrow
News | Mobile C-Arms

January 18, 2022 – Philips Healthcare announced physicians will now have access to advanced new 3D image guidance ...

Time January 18, 2022
arrow
Feature | Mobile C-Arms | By Bhvita Jani

With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resources ...

Time July 07, 2021
arrow
News | Angiography

December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided ...

Time December 01, 2020
arrow
News | Mobile C-Arms

August 18, 2020 — Ziehm Imaging announces the acquisition of Therenva, a French-based developer of planning and imaging ...

Time August 18, 2020
arrow
News | Computed Tomography (CT)

February 10, 2020 — The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by ...

Time February 10, 2020
arrow
Feature | RSNA | Dave Fornell, Editor

Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the Radiological ...

Time January 20, 2020
arrow
Subscribe Now